JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, M.
Right arrow Articles by Udenfriend, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, M.
Right arrow Articles by Udenfriend, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Kinetic Study of Bovine Adrenal Tyrosine Hydroxylase

Masayuki Ikeda 1, Leonard A. Fahien 1, and Sidney Udenfriend 1

From the 1 From the Laboratory of Clinical Biochemistry, National Heart Institute, National Institutes of Health, Bethesda, Maryland 20014

Kinetic data are presented which are consistent with the concept that the mechanism of tyrosine hydroxylase involves the following sequential steps: (a) reduction of an oxidized form of the enzyme by 2-amino-4-hydroxy-6,7-dimethyltetrahydropteridine (DMPH4) followed by dissociation of the oxidized pteridine, and (b) aerobic oxidation of tyrosine, producing 3,4-dihydroxyphenylalanine (dopa) and the oxidized form of the enzyme. This concept is supported by studies of the effects of the substrates on initial velocities as well as by the use of dopa and analogues of substrates and products as inhibitors. Tyrosine and its analogues bind to a reduced form of the enzyme, while dopa and its analogues bind to an oxidized form of the enzyme. Deviations from this pattern occur at concentrations several times the Michaelis constant. At such concentrations tyrosine and its analogues can be bound to an oxidized form of the enzyme, while dopa and its analogues and DMPH4 can be bound to a reduced form of the enzyme.

Submitted on February 21, 1966


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
J.-M. TRIFARO
Molecular Biology of the Chromaffin Cell
Ann. N.Y. Acad. Sci., October 1, 2002; 971(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Ramsey, P. J. Hillas, and P. F. Fitzpatrick
Characterization of the Active Site Iron in Tyrosine Hydroxylase. REDOX STATES OF THE IRON
J. Biol. Chem., October 4, 1996; 271(40): 24395 - 24400.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P Lerner, P Nose, E. Gordon, and W Lovenberg
Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover
Science, July 8, 1977; 197(4299): 181 - 183.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1966 by the American Society for Biochemistry and Molecular Biology.